Inner Mongolia Furui Med Sci (300049) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.050x

Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.06 Million ≈ $20.35 Million USD) by net assets (CN¥2.79 Billion ≈ $407.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Inner Mongolia Furui Med Sci - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Inner Mongolia Furui Med Sci's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Inner Mongolia Furui Med Sci total liabilities for a breakdown of total debt and financial obligations.

Inner Mongolia Furui Med Sci Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Coty Inc
NYSE:COTY
0.147x
Shenzhen Topband Co Ltd
SHE:002139
0.029x
OPT Machine Vision Tech Co. Ltd. A
SHG:688686
0.005x
Guobang Pharma Ltd
SHG:605507
0.038x
WHA Corporation Public Company Limited
BK:WHA-R
0.001x
Nuvoton Technology Corp
TW:4919
0.002x
NCC AB (publ)
ST:NCC-B
-0.008x
NOS S.G.P.S. S.A.
LS:NOS
0.145x

Annual Cash Flow Conversion Efficiency for Inner Mongolia Furui Med Sci (2006–2025)

The table below shows the annual cash flow conversion efficiency of Inner Mongolia Furui Med Sci from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Inner Mongolia Furui Med Sci.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.79 Billion
≈ $407.78 Million
CN¥354.15 Million
≈ $51.82 Million
0.127x +22.14%
2024-12-31 CN¥2.13 Billion
≈ $311.38 Million
CN¥221.41 Million
≈ $32.40 Million
0.104x -36.95%
2023-12-31 CN¥1.85 Billion
≈ $270.33 Million
CN¥304.89 Million
≈ $44.61 Million
0.165x +59.05%
2022-12-31 CN¥1.83 Billion
≈ $267.18 Million
CN¥189.46 Million
≈ $27.72 Million
0.104x -15.81%
2021-12-31 CN¥1.81 Billion
≈ $264.23 Million
CN¥222.55 Million
≈ $32.57 Million
0.123x -0.52%
2020-12-31 CN¥1.62 Billion
≈ $236.40 Million
CN¥200.15 Million
≈ $29.29 Million
0.124x -24.98%
2019-12-31 CN¥1.55 Billion
≈ $227.04 Million
CN¥256.23 Million
≈ $37.49 Million
0.165x +219.10%
2018-12-31 CN¥1.51 Billion
≈ $221.53 Million
CN¥78.35 Million
≈ $11.46 Million
0.052x -24.72%
2017-12-31 CN¥1.92 Billion
≈ $280.39 Million
CN¥131.72 Million
≈ $19.27 Million
0.069x -15.69%
2016-12-31 CN¥1.83 Billion
≈ $267.13 Million
CN¥148.84 Million
≈ $21.78 Million
0.082x -14.91%
2015-12-31 CN¥1.65 Billion
≈ $241.53 Million
CN¥158.16 Million
≈ $23.14 Million
0.096x +72.35%
2014-12-31 CN¥915.10 Million
≈ $133.91 Million
CN¥50.88 Million
≈ $7.44 Million
0.056x +47.66%
2013-12-31 CN¥748.53 Million
≈ $109.53 Million
CN¥28.18 Million
≈ $4.12 Million
0.038x -67.84%
2012-12-31 CN¥733.64 Million
≈ $107.35 Million
CN¥85.88 Million
≈ $12.57 Million
0.117x +8.65%
2011-12-31 CN¥703.08 Million
≈ $102.88 Million
CN¥75.75 Million
≈ $11.08 Million
0.108x +50.54%
2010-12-31 CN¥687.42 Million
≈ $100.59 Million
CN¥49.20 Million
≈ $7.20 Million
0.072x +637.68%
2009-12-31 CN¥157.46 Million
≈ $23.04 Million
CN¥-2.10 Million
≈ $-306.69K
-0.013x -105.09%
2008-12-31 CN¥139.52 Million
≈ $20.42 Million
CN¥36.47 Million
≈ $5.34 Million
0.261x +87.15%
2007-12-31 CN¥127.76 Million
≈ $18.70 Million
CN¥17.85 Million
≈ $2.61 Million
0.140x -64.88%
2006-12-31 CN¥124.50 Million
≈ $18.22 Million
CN¥49.52 Million
≈ $7.25 Million
0.398x --

About Inner Mongolia Furui Med Sci

SHE:300049 China Biotechnology
Market Cap
$1.95 Billion
CN¥13.34 Billion CNY
Market Cap Rank
#6369 Global
#1422 in China
Share Price
CN¥50.36
Change (1 day)
-0.36%
52-Week Range
CN¥29.85 - CN¥87.87
All Time High
CN¥87.87
About

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules… Read more